Quantum Cyber (QUCY) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.06, -2.75% vs the prior close of $1.09.
- Volume 336.90K shares, 0.5x its 50-day average (light).
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
QUCY dips 2.8% to $1.06. Closed at $1.06, -2.75% vs the prior close of $1.09. Day range $1.05–$1.12, opened at $1.12.
QUCY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — QUCY dips 2.8% to $1.06
- Closed at $1.06, -2.75% vs the prior close of $1.09. Day range $1.05–$1.12, opened at $1.12.
- Volume was 336.90K shares, 0.5x its 50-day average of 685.78K — lighter than usual.
- Price is -21.7% vs its 50-day average ($1.35) and -13.2% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 16% of that range, 78.5% below the 52-week high.
Oct 15, 2026 — QUCY jumps 5.8% to $1.09
- Closed at $1.09, +5.83% vs the prior close of $1.03. Day range $1.01–$1.12, opened at $1.03.
- Volume was 568.80K shares, 0.8x its 50-day average of 693.39K.
- Price is -19.9% vs its 50-day average ($1.36) and -10.8% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 17% of that range, 77.9% below the 52-week high.
Oct 14, 2026 — QUCY slides 8.0% to $1.03
- Closed at $1.03, -8.04% vs the prior close of $1.12. Day range $1.00–$1.10, opened at $1.09.
- Volume was 376.70K shares, 0.5x its 50-day average of 725.97K — lighter than usual.
- Price is -24.7% vs its 50-day average ($1.37) and -15.7% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 16% of that range, 79.1% below the 52-week high.
Oct 13, 2026 — QUCY jumps 8.7% to $1.12
- Closed at $1.12, +8.74% vs the prior close of $1.03. Day range $1.02–$1.13, opened at $1.03.
- Volume was 543.50K shares, 0.7x its 50-day average of 730.17K.
- Price is -18.7% vs its 50-day average ($1.38) and -8.5% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 18% of that range, 77.3% below the 52-week high.
Oct 12, 2026 — QUCY slides 23.7% to $1.03, a 3-month low on 2.9x normal volume
- Closed at $1.03, -23.70% vs the prior close of $1.35. Day range $0.90–$1.23, opened at $1.20.
- Volume was 2.05M shares, 2.9x its 50-day average of 699.09K — unusually heavy trading.
- Price is -25.4% vs its 50-day average ($1.38) and -15.8% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 16% of that range, 79.1% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — QUCY dips 2.9% to $1.35
- Closed at $1.35, -2.88% vs the prior close of $1.39. Day range $1.34–$1.41, opened at $1.38.
- Volume was 637.10K shares, 0.9x its 50-day average of 693.67K.
- Price is -2.3% vs its 50-day average ($1.38) and +10.3% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 23% of that range, 72.6% below the 52-week high.
- SEC filings that day: 8-K, 424B5.
Oct 8, 2026 — QUCY dips 2.8% to $1.39
- Closed at $1.39, -2.80% vs the prior close of $1.43. Day range $1.37–$1.49, opened at $1.39.
- Volume was 630.30K shares, 0.9x its 50-day average of 695.82K.
- Price is +0.9% vs its 50-day average ($1.38) and +13.6% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 24% of that range, 71.8% below the 52-week high.
Oct 7, 2026 — QUCY jumps 10.9% to $1.43, a 1-month high on 2.2x normal volume
- Closed at $1.43, +10.85% vs the prior close of $1.29. Day range $1.25–$1.50, opened at $1.27.
- Volume was 1.46M shares, 2.2x its 50-day average of 676.34K — unusually heavy trading.
- Price is +4.3% vs its 50-day average ($1.37) and +17.0% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 24% of that range, 71.0% below the 52-week high.
Oct 6, 2026 — QUCY slides 4.4% to $1.29
- Closed at $1.29, -4.44% vs the prior close of $1.35. Day range $1.29–$1.36, opened at $1.35.
- Volume was 243.50K shares, 0.4x its 50-day average of 680.21K — lighter than usual.
- Price is -5.4% vs its 50-day average ($1.36) and +5.6% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 21% of that range, 73.8% below the 52-week high.
Oct 5, 2026 — QUCY rises 1.5% to $1.35
- Closed at $1.35, +1.50% vs the prior close of $1.33. Day range $1.31–$1.36, opened at $1.31.
- Volume was 274.30K shares, 0.4x its 50-day average of 686.87K — lighter than usual.
- Price is -0.8% vs its 50-day average ($1.36) and +10.7% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 23% of that range, 72.6% below the 52-week high.
Oct 2, 2026 — QUCY dips 1.5% to $1.33
- Closed at $1.33, -1.48% vs the prior close of $1.35. Day range $1.29–$1.36, opened at $1.36.
- Volume was 453.80K shares, 0.7x its 50-day average of 687.30K.
- Price is -1.8% vs its 50-day average ($1.35) and +9.2% vs its 200-day average ($1.22).
- 52-week range $0.30–$4.93; today's close sits at 22% of that range, 73.0% below the 52-week high.
QUCY latest news & SEC filings
Every SEC filing by or about QUCY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Oct 9, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 25, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$11.02M (prior year -$3.48M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.62 (prior year -$0.80) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade QUCY
- How much it moves: over the last 20 sessions the average daily move was 4.73% (largest 23.7%). That is a volatile stock.
- Liquidity: about 515.91K shares (≈$546.86K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.06 vs a range of $0.30–$4.93 (16% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Kevin Michael Donahue bought 685,000 shares on Oct 17, 2025.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 9, 2026; 8-K Sep 25, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
QUCY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.12 | 1.12 | 1.05 | 1.06 | 336.90K |
| Oct 15, 2026 | 1.03 | 1.12 | 1.01 | 1.09 | 568.80K |
| Oct 14, 2026 | 1.09 | 1.10 | 1.00 | 1.03 | 376.70K |
| Oct 13, 2026 | 1.03 | 1.13 | 1.02 | 1.12 | 543.50K |
| Oct 12, 2026 | 1.20 | 1.23 | 0.90 | 1.03 | 2.05M |
| Oct 9, 2026 | 1.38 | 1.41 | 1.34 | 1.35 | 637.10K |
| Oct 8, 2026 | 1.39 | 1.49 | 1.37 | 1.39 | 630.30K |
| Oct 7, 2026 | 1.27 | 1.50 | 1.25 | 1.43 | 1.46M |
| Oct 6, 2026 | 1.35 | 1.36 | 1.29 | 1.29 | 243.50K |
| Oct 5, 2026 | 1.31 | 1.36 | 1.31 | 1.35 | 274.30K |
| Oct 2, 2026 | 1.36 | 1.36 | 1.29 | 1.33 | 453.80K |
| Oct 1, 2026 | 1.31 | 1.38 | 1.25 | 1.35 | 446.30K |
| Sep 30, 2026 | 1.32 | 1.35 | 1.31 | 1.31 | 147.50K |
| Sep 29, 2026 | 1.37 | 1.37 | 1.29 | 1.29 | 229.30K |
| Sep 28, 2026 | 1.36 | 1.38 | 1.33 | 1.36 | 205.30K |
| Sep 25, 2026 | 1.35 | 1.38 | 1.31 | 1.37 | 498.60K |
| Sep 24, 2026 | 1.32 | 1.34 | 1.28 | 1.33 | 253.30K |
| Sep 23, 2026 | 1.34 | 1.36 | 1.30 | 1.32 | 241.90K |
| Sep 22, 2026 | 1.30 | 1.35 | 1.29 | 1.32 | 384.50K |
| Sep 21, 2026 | 1.37 | 1.38 | 1.30 | 1.30 | 330.40K |
About Quantum Cyber
Quantum Cyber (QUCY) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MAINZ. State of incorporation: Netherlands. Fiscal year ends December 31. SEC CIK 1874252.
QUCY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Guido Baechler | Chief Executive Officer | Feb 19, 2026 |
| Avraham Ben-Tzvi | Director | Aug 6, 2026 |
| Louis R. Buffalino | Director | Aug 6, 2026 |
| Heinrich Dreismann | Director | Feb 19, 2026 |
| Hans Hekland | Director | Feb 19, 2026 |
| David E. Lazar | Chief Executive Officer | Aug 7, 2026 |
| David Natan | Director | Aug 6, 2026 |
| Peter O'Rourke | Director | Aug 6, 2026 |
| Gregory J Tibbitts | Director | Feb 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Guido Baechler | Chief Executive Officer | Feb 19, 2026 |
| William J Caragol | Chief Financial Officer | Aug 12, 2026 |
| David E. Lazar | Chief Executive Officer | Aug 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 685,000 | $1.51 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 685,000 | $1.51 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 685,000 | $1.51 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 685,000 | $1.51 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 643,850 | $402,000.00 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 643,850 | $402,000.00 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 643,850 | $402,000.00 |
| Oct 17, 2025 | Kevin Michael Donahue | Buy | 643,850 | $402,000.00 |
QUCY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $537.08K | $-16.21M | -2.70 | $-10.98M |
| Dec 31, 2024 | $893.99K | $-21.60M | -21.91 | $-17.33M |
Latest balance sheet: total assets $23.37M, total liabilities $3.00M, cash $13.40M (as of Jun 30, 2026).
QUCY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on QUCY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.